Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 2
2006 3
2007 1
2008 8
2009 5
2010 5
2011 5
2012 8
2013 4
2014 7
2015 9
2016 10
2017 9
2018 4
2019 5
2020 9
2021 13
2022 16
2023 9
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. Doki Y, et al. N Engl J Med. 2022 Feb 3;386(5):449-462. doi: 10.1056/NEJMoa2111380. N Engl J Med. 2022. PMID: 35108470 Clinical Trial.
Safety and activity of trifluridine/tipiracil and ramucirumab in previously treated advanced gastric cancer: an open-label, single-arm, phase 2 trial.
Kawazoe A, Ando T, Hosaka H, Fujita J, Koeda K, Nishikawa K, Amagai K, Fujitani K, Ogata K, Watanabe K, Yamamoto Y, Shitara K. Kawazoe A, et al. Among authors: ando t. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):209-217. doi: 10.1016/S2468-1253(20)30396-4. Epub 2021 Jan 26. Lancet Gastroenterol Hepatol. 2021. PMID: 33508242 Clinical Trial.
Screening method toward ClbP-specific inhibitors.
Zhou T, Ando T, Kudo A, Sato M, Miyoshi N, Mutoh M, Ishikawa H, Wakabayashi K, Watanabe K. Zhou T, et al. Among authors: ando t. Genes Environ. 2023 Feb 16;45(1):8. doi: 10.1186/s41021-023-00264-7. Genes Environ. 2023. PMID: 36797758 Free PMC article.
ARID1A loss-of-function induces CpG island methylator phenotype.
Yamada H, Takeshima H, Fujiki R, Yamashita S, Sekine S, Ando T, Hattori N, Okabe A, Yoshikawa T, Obama K, Katai H, Kaneda A, Ushijima T. Yamada H, et al. Among authors: ando t. Cancer Lett. 2022 Apr 28;532:215587. doi: 10.1016/j.canlet.2022.215587. Epub 2022 Feb 5. Cancer Lett. 2022. PMID: 35131383
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Aoki M, Kadowaki S, Takahashi N, Suzuki T, Oshima K, Ando T, Yamamoto Y, Kawakami K, Kito Y, Matsumoto T, Shimozaki K, Miyazaki Y, Yamaguchi T, Nagase M, Tamura T, Amanuma Y, Esaki T, Miura Y, Akiyoshi K, Baba E, Makiyama A, Negoro Y, Nakashima K, Sugimoto N, Nagashima K, Shoji H, Boku N. Aoki M, et al. Among authors: ando t. Gastric Cancer. 2023 Jan;26(1):132-144. doi: 10.1007/s10120-022-01349-y. Epub 2022 Nov 1. Gastric Cancer. 2023. PMID: 36316527 Free PMC article.
Antiviral effect of theaflavins against caliciviruses.
Ohba M, Oka T, Ando T, Arahata S, Ikegaya A, Takagi H, Ogo N, Zhu C, Owada K, Kawamori F, Wang Q, Saif LJ, Asai A. Ohba M, et al. Among authors: ando t. J Antibiot (Tokyo). 2017 Apr;70(4):443-447. doi: 10.1038/ja.2016.128. Epub 2016 Oct 19. J Antibiot (Tokyo). 2017. PMID: 27756911
Colonic TRPV4 overexpression is related to constipation severity.
Mihara H, Uchida K, Watanabe Y, Nanjo S, Sakumura M, Motoo I, Ando T, Minemura M, Muhammad JS, Yamamoto H, Itoh F, Yasuda I. Mihara H, et al. Among authors: ando t. BMC Gastroenterol. 2023 Jan 13;23(1):13. doi: 10.1186/s12876-023-02647-0. BMC Gastroenterol. 2023. PMID: 36639736 Free PMC article.
129 results